**5.6 End-stage kidney disease due to congenital obstructive nephropathy**

For patients with congenital obstructive nephropathy who progress to ESRD, renal transplantation is generally a safe and effective therapy, with 5 year graft survival rates approximately 85% for living donor transplants and 72% for deceased donor grafts in patients with a primary diagnosis of obstructive nephropathy (NAPRTCS, 2009). Appropriate and effective management of any residual urinary tract dysfunction is critical to long-term outcomes following renal transplantation in patients with congenital obstructive nephropathy (Morita et al., 2009).
